slides · global inventory
All filtered slides
Global slide inventory for the active corpus filters, with each row opening the slide detail view.
Corpus coverage
319,975 slides
319,974 are described (100%), so the treemap can explain the corpus instead of just counting files.
- Total slides
- 319,975
- Described
- 319,974
- Pending
- 1
100%ready for canon
Slide type composition
dynamicclickable
Slide type
Showing 319,974 described slides — 100.0% of 319,975 rendered pages
+Context & problem43,76713.7% · 6,592 docs+Data & charts72,62022.7% · 8,666 docs+Meta & navigation45,93614.4% · 9,739 docs+Recommend & act67,04121.0% · 9,324 docs+Cases & evidence31,2569.8% · 6,067 docs+Frameworks2,1230.7% · 1,232 docs+Appendix35,68211.2% · 6,614 docs+Other21,5496.7% · 5,566 docs
Tile area is proportional to slide count. Click a category to open its subtype map.
all document kinds · all orientations
Slide collection
62,281-62,340 of 319,975
74
2026 Investor Day2026 Investor Day · JBT Marel
Consulting deck Strategy consulting Beat · Action1 hit
75
2026 Investor Day2026 Investor Day · JBT Marel
Consulting deck Strategy consulting Beat · Action1 hit
76
2026 Investor Day2026 Investor Day · JBT Marel
Consulting deck Strategy consulting Beat · Action1 hit
77
Uses a causal chain/process flow structure to link inputs to outcomes.2026 Investor Day · JBT Marel
Consulting deck Strategy consulting Beat · Action1 hit
78
The slide uses a three-column layout connecting segments, drivers, and value proposition via plus-sign icons.2026 Investor Day · JBT Marel
Consulting deck Strategy consulting Beat · Action1 hit
79
The slide uses a three-column structure to detail strategic drivers, with a central 'Order Synergy Examples' box and a bottom summary callout.2026 Investor Day · JBT Marel
Consulting deck Strategy consulting Beat · Action1 hit
80
The slide highlights the transition from initial resource optimization to supply chain initiatives.2026 Investor Day · JBT Marel
Consulting deck Strategy consulting Beat · Action1 hit
81
The slide uses a two-column layout to categorize operational excellence initiatives.2026 Investor Day · JBT Marel
Consulting deck Strategy consulting Beat · Action1 hit
82
The slide highlights the drivers of FCF (resilient markets, working capital, low capex) and provides a financial bridge/table for 2025.2026 Investor Day · JBT Marel
Consulting deck Strategy consulting Beat · Action1 hit
83
The slide uses a two-column layout to contrast deleveraging performance with debt structure.2026 Investor Day · JBT Marel
Consulting deck Strategy consulting Beat · Action1 hit
84
The slide uses a two-part framework: a horizontal list for capital allocation and a side-by-side comparison for M&A criteria.2026 Investor Day · JBT Marel
Consulting deck Strategy consulting Beat · Action1 hit
85
The slide uses a dark blue background with a list of four key financial metrics and their corresponding targets.2026 Investor Day · JBT Marel
Consulting deck Strategy consulting Beat · Action1 hit
86
The chart uses a waterfall structure to bridge the 2025 actual revenue to the 2028 expected revenue.2026 Investor Day · JBT Marel
Consulting deck Strategy consulting Beat · Action1 hit
87
The chart shows a margin expansion from 15.8% to 20% over the period.2026 Investor Day · JBT Marel
Consulting deck Strategy consulting Beat · Action1 hit
88
The slide uses a table to contrast financial performance and outlooks for Protein Solutions and Prepared Food and Beverage Solutions.2026 Investor Day · JBT Marel
Consulting deck Strategy consulting Beat · Action1 hit
89
2026 Investor Day2026 Investor Day · JBT Marel
Consulting deck Strategy consulting Beat · Action1 hit
90
2026 Investor Day2026 Investor Day · JBT Marel
Consulting deck Strategy consulting Beat · Action1 hit
91
2026 Investor Day2026 Investor Day · JBT Marel
Consulting deck Strategy consulting Beat · Action1 hit
92
2026 Investor Day2026 Investor Day · JBT Marel
Consulting deck Strategy consulting Beat · Action1 hit
93
2026 Investor Day2026 Investor Day · JBT Marel
Consulting deck Strategy consulting Beat · Action1 hit
94
2026 Investor Day2026 Investor Day · JBT Marel
Consulting deck Strategy consulting Beat · Action1 hit
95
Includes detailed footnotes explaining the nature of adjustments (financing income, pension expense, restructuring, M&A costs, D&A).2026 Investor Day · JBT Marel
Consulting deck Strategy consulting Beat · Action1 hit
96
2026 Investor Day2026 Investor Day · JBT Marel
Consulting deck Strategy consulting Beat · Action1 hit
01
2026 Investor Deck2026 Investor Deck · Summit Therapeutics
Consulting deck Strategy consulting 1 hit
02
Includes specific disclaimer about ivonescimab regulatory status and copyright information.2026 Investor Deck · Summit Therapeutics
Consulting deck Strategy consulting 1 hit
03
The slide highlights a major regulatory milestone for the company's lead asset.2026 Investor Deck · Summit Therapeutics
Consulting deck Strategy consulting Loop · Cost Of Inaction1 hit
04
Includes both Summit and Akeso trials.2026 Investor Deck · Summit Therapeutics
Consulting deck Strategy consulting Beat · SolutionLoop · Cost Of Inaction1 hit
05
The slide uses a scientific illustration to explain the molecular mechanism of a bispecific antibody.2026 Investor Deck · Summit Therapeutics
Consulting deck Strategy consulting Loop · Cost Of Inaction1 hit
06
The table uses a visual bar representation for clinical trial phases (1/1b, 2, 3).2026 Investor Deck · Summit Therapeutics
Consulting deck Strategy consulting Beat · ProductLoop · Cost Of Inaction1 hit
07
Includes a table of clinical trials, callout boxes for collaborations and research support, and a forward-looking statement about Q1 2026.2026 Investor Deck · Summit Therapeutics
Consulting deck Strategy consulting Loop · Cost Of Inaction1 hit
08
The slide uses a structured grid to compare four distinct clinical trial programs.2026 Investor Deck · Summit Therapeutics
Consulting deck Strategy consulting Loop · Cost Of Inaction1 hit
09
The slide presents clinical trial data for Ivonescimab in NSCLC, showing consistent HR improvements across different patient populations.2026 Investor Deck · Summit Therapeutics
Consulting deck Strategy consulting Loop · Cost Of Inaction1 hit
10
The slide uses a dual-column timeline layout to track progress of various HARMONI clinical trials.2026 Investor Deck · Summit Therapeutics
Consulting deck Strategy consulting Loop · Cost Of Inaction1 hit
11
The slide uses a checkmark visual to indicate positive outcomes for each clinical question posed.2026 Investor Deck · Summit Therapeutics
Consulting deck Strategy consulting Loop · Cost Of Inaction1 hit
12
The slide uses a timeline framework to communicate upcoming clinical trial readouts and regulatory events.2026 Investor Deck · Summit Therapeutics
Consulting deck Strategy consulting Loop · Cost Of Inaction1 hit
13
The slide highlights a strong liquidity position with significant cash and zero debt.2026 Investor Deck · Summit Therapeutics
Consulting deck Strategy consulting Beat · FinancialsLoop · Cost Of Inaction1 hit
14
The slide uses a visual flow to aggregate market sizes and point toward future growth areas.2026 Investor Deck · Summit Therapeutics
Consulting deck Strategy consulting Beat · Market SizeLoop · Cost Of Inaction1 hit
15
2026 Investor Deck2026 Investor Deck · Summit Therapeutics
Consulting deck Strategy consulting Loop · Cost Of Inaction1 hit
01
Includes CEO quote and segment-specific product/category icons.2026 Q1 Earnings · Johnson & Johnson
Consulting deck Strategy consulting 1 hit
02
2026 Q1 Earnings2026 Q1 Earnings · Johnson & Johnson
Consulting deck Strategy consulting 1 hit
03
2026 Q1 Earnings2026 Q1 Earnings · Johnson & Johnson
Consulting deck Strategy consulting 1 hit
04
2026 Q1 Earnings2026 Q1 Earnings · Johnson & Johnson
Consulting deck Strategy consulting 1 hit
05
2026 Q1 Earnings2026 Q1 Earnings · Johnson & Johnson
Consulting deck Strategy consulting 1 hit
06
2026 Q1 Earnings2026 Q1 Earnings · Johnson & Johnson
Consulting deck Strategy consulting Beat · Team1 hit
07
The slide uses a grid of images to represent business units, with a primary metric highlighted on the left.2026 Q1 Earnings · Johnson & Johnson
Consulting deck Strategy consulting Beat · Problem1 hit
08
The slide uses a grid layout to showcase product logos under three main therapeutic pillars.2026 Q1 Earnings · Johnson & Johnson
Consulting deck Strategy consulting Beat · Solution1 hit
09
2026 Q1 Earnings2026 Q1 Earnings · Johnson & Johnson
Consulting deck Strategy consulting Beat · Solution1 hit
10
The slide uses a grid layout to showcase product logos under three main therapeutic pillars.2026 Q1 Earnings · Johnson & Johnson
Consulting deck Strategy consulting Beat · Solution1 hit
11
The slide uses a three-column layout to categorize products by medical specialty.2026 Q1 Earnings · Johnson & Johnson
Consulting deck Strategy consulting Beat · Team1 hit
12
2026 Q1 Earnings2026 Q1 Earnings · Johnson & Johnson
Consulting deck Strategy consulting Beat · Team1 hit
13
2026 Q1 Earnings2026 Q1 Earnings · Johnson & Johnson
Consulting deck Strategy consulting Beat · Team1 hit
14
The table includes a footnote regarding non-GAAP measures and currency impact.2026 Q1 Earnings · Johnson & Johnson
Consulting deck Strategy consulting Beat · Financials1 hit
15
The slide uses a consistent color scheme (dark blue for 2026, light blue for 2025) to compare quarterly performance.2026 Q1 Earnings · Johnson & Johnson
Consulting deck Strategy consulting Beat · Financials1 hit
16
Includes a donut chart showing sales breakdown by segment and a table detailing operational drivers.2026 Q1 Earnings · Johnson & Johnson
Consulting deck Strategy consulting Beat · Financials1 hit
17
The slide uses a donut chart to show total sales and growth, and a table-like structure to detail drivers by business unit.2026 Q1 Earnings · Johnson & Johnson
Consulting deck Strategy consulting Beat · Financials1 hit
18
Includes both GAAP and non-GAAP (adjusted) financial metrics.2026 Q1 Earnings · Johnson & Johnson
Consulting deck Strategy consulting Beat · Financials1 hit
19
Includes footnotes regarding non-GAAP measures and segment allocations.2026 Q1 Earnings · Johnson & Johnson
Consulting deck Strategy consulting Beat · Financials1 hit
20
2026 Q1 Earnings2026 Q1 Earnings · Johnson & Johnson
Consulting deck Strategy consulting 1 hit
21
The slide uses a hierarchical flow chart to show capital allocation priorities, with R&D and dividends highlighted as specific outcomes.2026 Q1 Earnings · Johnson & Johnson
Consulting deck Strategy consulting 1 hit
22
The table compares two sets of financial guidance projections for the same fiscal year.2026 Q1 Earnings · Johnson & Johnson
Consulting deck Strategy consulting Loop · Cost Of Inaction1 hit